Hepatoblastoma PRETEXT Staging and Management
The PRETEXT (Pretreatment Extent of Disease) staging system divides the liver into four sections and guides surgical resectability and early transplant referral, with the gold standard treatment being cisplatin-based chemotherapy followed by complete surgical resection or liver transplantation for unresectable disease. 1
PRETEXT Staging System
The PRETEXT system assesses tumor extent at diagnosis by evaluating involvement of the four hepatic sections and is used to triage patients for early referral to centers with both pediatric hepatobiliary surgery and liver transplantation expertise. 1
PRETEXT Classification
- PRETEXT I-II: Tumor confined to 1-2 hepatic sections, typically resectable with conventional hepatectomy 2
- PRETEXT III: Tumor involves 3 hepatic sections; may be resectable depending on annotation factors 1
- PRETEXT IV: Tumor involves all 4 hepatic sections; typically requires liver transplantation 1
Critical Annotation Factors
The following annotation factors significantly impact prognosis and surgical planning:
- V (venous involvement): Involvement of hepatic veins or inferior vena cava 1
- P (portal involvement): Portal vein involvement or thrombosis 1
- E (extrahepatic disease): Direct extension beyond liver capsule 3
- F (multifocal disease): Multiple discrete tumor nodules 3
- R (tumor rupture): Spontaneous or iatrogenic rupture 1
- C (caudate lobe involvement): Involvement of segment I 1
- M (metastases): Distant metastases, most commonly pulmonary 1
Complex PRETEXT III disease (multifocal or with venous thrombosis) or centrally located tumors have poor outcomes with chemotherapy and surgical resection alone and require early transplant evaluation. 1
Management Algorithm
Step 1: Immediate Actions at Diagnosis
- Refer all children with suspected hepatoblastoma immediately to a pediatric liver transplant center for multidisciplinary evaluation involving pediatric gastroenterology, hepatobiliary surgery, transplant surgery, and oncology. 1, 4
- Obtain baseline serum alpha-fetoprotein (AFP); levels >1,000 ng/dL are typical of hepatoblastoma. 4
- Perform contrast-enhanced abdominal CT or MRI with multiphasic technique to characterize the mass and define PRETEXT stage. 4
- Obtain chest CT to detect pulmonary metastases, which is essential for staging. 4, 5
Step 2: Risk Stratification and Early Transplant Referral
Children with nonmetastatic but otherwise unresectable hepatoblastoma must be referred for liver transplant evaluation at diagnosis or no later than after 2 rounds of chemotherapy. 1, 5
High-Risk Features Requiring Early Transplant Center Involvement:
- PRETEXT IV disease (all 4 sections involved) 1
- Complex PRETEXT III disease (multifocal or venous thrombosis) 1
- Centrally located tumors where tumor-free excision is unlikely 1
- Age ≥3 years with advanced disease 6
- Presence of multiple annotation factors 1
Step 3: Initiate Chemotherapy
- Begin cisplatin-based chemotherapy immediately according to the Children's Oncology Group protocol (COG-AHEP0731). 1, 5
- Administer sodium thiosulfate (16-20 g/m²) 6 hours after each cisplatin dose to prevent ototoxicity without compromising survival. 4
- Reassess tumor resectability after 2-4 cycles of chemotherapy. 1, 5
Step 4: Surgical Decision After Chemotherapy Response
After 2-4 chemotherapy cycles, proceed according to this hierarchy based on tumor response and resectability: 1, 5
If Complete Resection with Negative Margins is Achievable:
- Proceed with conventional hepatic resection (partial hepatectomy). 1, 5
- Ensure sufficient functional residual hepatic mass remains. 1
If Tumor Remains Unresectable but Confined to Liver:
- Proceed to primary liver transplantation, which achieves 82% 10-year survival. 1, 5
- This is vastly superior to "rescue" transplantation after failed resection, which achieves only 30% 10-year survival. 1, 5
Step 5: Management of Metastatic Disease
Children with pulmonary metastases at diagnosis can still achieve curative outcomes if specific criteria are met after chemotherapy: 1, 5
- Pulmonary metastases are no longer visible on chest CT after chemotherapy 1
- OR residual pulmonary nodules are completely resected with tumor-free margins confirmed on pathology 1
Recurrence-free survival following liver transplantation is similar between patients with resolved pulmonary metastases and those without metastases at diagnosis. 1
Critical Pitfalls to Avoid
Timing of Transplant Referral
Do not delay transplant referral beyond 2 chemotherapy cycles for clearly unresectable disease; this drops survival from 82% to 30%. 1, 5
Only 65% of patients meeting criteria for early transplant referral in the COG-AHEP0731 trial were referred within the recommended timeframe, representing a significant missed opportunity. 7
Surgical Decision-Making
Avoid aggressive conventional resection when positive margins are anticipated; this converts a primary transplant candidate (82% survival) into a rescue transplant candidate (30% survival). 1, 5
Do not attempt marginal resections that compromise future transplant candidacy. 5
Metastatic Disease
Do not exclude patients with pulmonary metastases from curative intent; complete resection after chemotherapy can yield outcomes comparable to non-metastatic disease. 1, 5
Misapplication of Criteria
Do not apply adult hepatocellular carcinoma criteria (Milan criteria) to hepatoblastoma; children can achieve excellent outcomes with much larger tumors due to superior chemosensitivity and tumor biology. 5
Biopsy Considerations
Do not perform liver biopsy when imaging and AFP are diagnostic, to prevent tumor seeding. 4
Prognostic Data Informing Treatment Decisions
Survival by Treatment Modality
- Primary liver transplantation for unresectable hepatoblastoma: 82% 10-year survival 1, 5
- "Rescue" transplantation after failed resection: 30% 10-year survival 1, 5
- Overall 5-year survival with modern multimodal therapy: 80-90% for localized disease 8
Impact of PRETEXT Stage
The prognostic significance of PRETEXT stage has evolved with modern treatment; advanced PRETEXT stages with positive annotation factors now achieve significantly improved survival compared to historical outcomes, particularly when appropriate transplantation is utilized. 3
Recent data show that aggressive resection in POST-TEXT III and IV patients can achieve 93% survival when performed at specialized centers. 1
Multidisciplinary Team Requirements
Optimal outcomes require coordinated care at a pediatric liver transplant center with: 1, 4